BTIS
INSY

BB&T Investment Services’s Insys Therapeutics, Inc. INSY Stock Holding History

BB&T Investment Services’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$22K Hold
2,210
– – ﹤0.01% 779
2017
Q3 		$20K Buy
+2,210
New +$22.8K ﹤0.01% 727

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BB&T Investment Services's INSY Position: Q4 2017 in Review

BB&T Investment Services held its Insys Therapeutics, Inc. (INSY) position steady in Q4 2017 at 2,210 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #779.

BB&T Investment Services first reported a position in INSY in Q3 2017 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold INSY as of Q4 2017.

  • BB&T Investment Services held 2,210 shares of Insys Therapeutics, Inc. worth $22K as of Q4 2017.
  • BB&T Investment Services left its Insys Therapeutics, Inc. share count unchanged in Q4 2017.
  • Insys Therapeutics, Inc. made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #779 holding.
  • BB&T Investment Services first reported a position in Insys Therapeutics, Inc. in Q3 2017 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.